2025 ICD-10 PCS INDEX TERMS STARTING WITH 3
- Introduction Upper GI to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0G3HZ
- Introduction Upper GI to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0G3KZ
- Introduction Upper GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0G3NZ
- Introduction Upper GI to Other Gas with Gas, Percutaneous Approach - 3E0G3SF
- Introduction Upper GI to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0G3TZ
- Introduction Upper GI to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E0G4GC
- Introduction Upper GI to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0G704
- Introduction Upper GI to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0G705
- Introduction Upper GI to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0G70M
- Introduction Upper GI to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E0G728
- Introduction Upper GI to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E0G729
- Introduction Upper GI to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0G73Z
- Introduction Upper GI to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Approach - 3E0G76Z
- Introduction Upper GI to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Approach - 3E0G77Z
- Introduction Upper GI to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E0G7BZ
- Introduction Upper GI to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E0G7GC
- Introduction Upper GI to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E0G7HZ
- Introduction Upper GI to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E0G7KZ
- Introduction Upper GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E0G7NZ
- Introduction Upper GI to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0G7SF
- Introduction Upper GI to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E0G7TZ
- Introduction Upper GI to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0G804
- Introduction Upper GI to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0G805
- Introduction Upper GI to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0G80M
- Introduction Upper GI to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0G828
- Introduction Upper GI to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0G829
- Introduction Upper GI to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Endoscopic Approach - 3E0G83Z
- Introduction Upper GI to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0G86Z
- Introduction Upper GI to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0G87Z
- Introduction Upper GI to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8BZ
- Introduction Upper GI to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8GC
- Introduction Upper GI to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8HZ
- Introduction Upper GI to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8KZ
- Introduction Upper GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8NZ
- Introduction Upper GI to Other Gas with Gas, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8SF
- Introduction Upper GI to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8TZ
- Introduction Lower GI to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0H304
- Introduction Lower GI to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0H305
- Introduction Lower GI to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0H30M
- Introduction Lower GI to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0H328
- Introduction Lower GI to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0H329
- Introduction Lower GI to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0H33Z
- Introduction Lower GI to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0H36Z
- Introduction Lower GI to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0H37Z
- Introduction Lower GI to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0H3BZ
- Introduction Lower GI to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0H3GC
- Introduction Lower GI to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0H3HZ
- Introduction Lower GI to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0H3KZ
- Introduction Lower GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0H3NZ
- Introduction Lower GI to Other Gas with Gas, Percutaneous Approach - 3E0H3SF
- Introduction Lower GI to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0H3TZ
- Introduction Lower GI to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E0H4GC
- Introduction Lower GI to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0H704
- Introduction Lower GI to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0H705
- Introduction Lower GI to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0H70M
- Introduction Lower GI to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E0H728
- Introduction Lower GI to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E0H729
- Introduction Lower GI to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0H73Z
- Introduction Lower GI to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Approach - 3E0H76Z
- Introduction Lower GI to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Approach - 3E0H77Z
- Introduction Lower GI to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E0H7BZ
- Introduction Lower GI to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E0H7GC
- Introduction Lower GI to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E0H7HZ
- Introduction Lower GI to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E0H7KZ
- Introduction Lower GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E0H7NZ
- Introduction Lower GI to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0H7SF
- Introduction Lower GI to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E0H7TZ
- Introduction Lower GI to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0H804
- Introduction Lower GI to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0H805
- Introduction Lower GI to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0H80M
- Introduction Lower GI to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0H828
- Introduction Lower GI to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0H829
- Introduction Lower GI to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Endoscopic Approach - 3E0H83Z
- Introduction Lower GI to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0H86Z
- Introduction Lower GI to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0H87Z
- Introduction Lower GI to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8BZ
- Introduction Lower GI to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8GC
- Introduction Lower GI to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8HZ
- Introduction Lower GI to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8KZ
- Introduction Lower GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8NZ
- Introduction Lower GI to Other Gas with Gas, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8SF
- Introduction Lower GI to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8TZ
- Introduction Biliary and Pancreatic Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0J304
- Introduction Biliary and Pancreatic Tract to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0J305
- Introduction Biliary and Pancreatic Tract to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0J30M
- Introduction Biliary and Pancreatic Tract to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0J328
- Introduction Biliary and Pancreatic Tract to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0J329
- Introduction Biliary and Pancreatic Tract to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0J33Z
- Introduction Biliary and Pancreatic Tract to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0J36Z
- Introduction Biliary and Pancreatic Tract to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0J37Z
- Introduction Biliary and Pancreatic Tract to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0J3BZ
- Introduction Biliary and Pancreatic Tract to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0J3GC
- Introduction Biliary and Pancreatic Tract to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0J3HZ
- Introduction Biliary and Pancreatic Tract to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0J3KZ
- Introduction Biliary and Pancreatic Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0J3NZ
- Introduction Biliary and Pancreatic Tract to Other Gas with Gas, Percutaneous Approach - 3E0J3SF
- Introduction Biliary and Pancreatic Tract to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0J3TZ
- Introduction Biliary and Pancreatic Tract to Autologous with Pancreatic Islet Cells, Percutaneous Approach - 3E0J3U0
- Introduction Biliary and Pancreatic Tract to Nonautologous with Pancreatic Islet Cells, Percutaneous Approach - 3E0J3U1
- Introduction Biliary and Pancreatic Tract to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E0J4GC